Silence Therapeutics to merge with Intradigm Corp of the US

Thursday 17 December 2009

Silence Therapeutics Plc, a company that has moved quickly to capitalise on the new science of ribonucleic acid interference (RNAi), has announced plans to merge with the privately-owned Intradigm Corp of the US, which is in the same business.

 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom